{"id":"NCT00174785","sponsor":"Sanofi","briefTitle":"A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation","officialTitle":"A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-06","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2005-09-15","resultsPosted":"2009-12-23","lastUpdate":"2010-01-12"},"enrollment":4628,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation","Atrial Flutter"],"interventions":[{"type":"DRUG","name":"dronedarone (SR33589)","otherNames":["Multaq®"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Dronedarone 400mg bid","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To assess the efficacy of dronedarone in preventing cardiovascular hospitalization or death from any cause in a population of high-risk patients with atrial fibrillation/atrial flutter (AF/AFL).\n\nTo assess that dronedarone is well tolerated in this population.","primaryOutcome":{"measure":"First Hospitalization for Cardiovascular Reason or Death From Any Cause","timeFrame":"minimum follow-up duration: 1 year ; maximum: 2.5 years","effectByArm":[{"arm":"Dronedarone 400mg Bid","deltaMin":734,"sd":null},{"arm":"Placebo","deltaMin":917,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"70 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":37,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","Chile","China","Czechia","Finland","Germany","Greece","Hong Kong","Hungary","India","Israel","Italy","Malaysia","Mexico","Morocco","Netherlands","New Zealand","Norway","Philippines","Poland","Portugal","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Tunisia","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["18031520","19213680","40295782","35717354","34958366","22770643","21576129","21296333","20436046"],"seeAlso":["http://www.sanofi-aventis.com"]},"adverseEventsSummary":{"seriousAny":{"events":456,"n":2291},"commonTop":["Any Gastrointestinal disorders","Any infections and infestations","Any general disorders and administration site conditions","Any musculoskeletal and connective tissue disorders","Any nervous system disorders"]}}